At diagnosis, Black people with pulmonary arterial hypertension (PAH) tend to have more severe disease than their non-Black counterparts,…
Articles by Marisa Wexler, MS
A study found that changes in immune cell metabolism may underlie increases in inflammatory signaling molecules in people with…
The rates of long-term survival and perioperative complications after a lung transplant in people with group 2 or group 3…
A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with pulmonary arterial hypertension (PAH)…
Adding Winrevair (sotatercept-csrk) to background treatment significantly reduces the risk of clinical worsening in people with a recent…
Enrollment is now complete — with nearly 400 participants with pulmonary arterial hypertension (PAH) — in the Phase 3 PROSERA…
Adding more lines of treatment may reduce the risk of rehospitalization among adults with pulmonary arterial hypertension (PAH) who…
People with pulmonary arterial hypertension (PAH) have abnormalities in their gut microbes that may play a role in their…
Soon after Yutrepia (treprostinil) was approved by the U.S. Food and Drug Administration (FDA) to treat some forms of…
Plans for a Phase 2b clinical trial that will test CS1, Cereno Scientific‘s experimental treatment for pulmonary arterial…
Most people with pulmonary arterial hypertension (PAH) who were treated with Uptravi (selexipag) and followed up for 10…
The first participant has been dosed in a Phase 2 trial testing the experimental oral therapy mirivadelgat in people with…